{
  "actions": [
    {
      "acted_at": "2017-02-09", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2017-02-09", 
      "action_code": "", 
      "committees": [
        "SSFI"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s348-115", 
  "bill_type": "s", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "115", 
  "cosponsors": [
    {
      "bioguide_id": "B000944", 
      "district": null, 
      "name": "Brown, Sherrod", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-02-09", 
      "state": "OH", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "G000555", 
      "district": null, 
      "name": "Gillibrand, Kirsten E.", 
      "original_cosponsor": false, 
      "sponsored_at": "2017-03-29", 
      "state": "NY", 
      "title": "Sen", 
      "withdrawn_at": null
    }, 
    {
      "bioguide_id": "R000122", 
      "district": null, 
      "name": "Reed, Jack", 
      "original_cosponsor": true, 
      "sponsored_at": "2017-02-09", 
      "state": "RI", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2017-02-09", 
  "number": "348", 
  "official_title": "A bill to amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr1776-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s771-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }, 
    {
      "bill_id": "s1688-115", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "Prescription Drug and Health Improvement Act of 2017", 
  "sponsor": {
    "bioguide_id": "F000457", 
    "district": null, 
    "name": "Franken, Al", 
    "state": "MN", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2017-02-09", 
  "subjects": [
    "Cancer", 
    "Congressional oversight", 
    "Drug therapy", 
    "Government information and archives", 
    "Government studies and investigations", 
    "Health", 
    "Health care costs and insurance", 
    "Medical research", 
    "Medicare", 
    "Prescription drugs", 
    "Public contracts and procurement", 
    "Veterans' medical care"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2017-02-09T05:00:00Z", 
    "text": "Prescription Drug and Health Improvement Act of 2017\n\nThis bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate lower prices on behalf of Medicare and Medicare Advantage (MA) beneficiaries for covered prescription drugs that the CMS deems appropriate for negotiation based on: (1) program and per-beneficiary spending, (2) unit price\u00a0increases over the preceding years, (3) initial launch price,\u00a0(4) availability of similarly effective alternative treatments, (5) status of the drug as a follow-on to previously approved drugs,\u00a0and (6) any other criteria determined by the CMS.\n\nIf, after a one year period, negotiations with respect to a covered prescription drug prove unsuccessful, the CMS shall establish a price for the drug that is equal to the lesser of the price paid by the Department of Veterans Affairs or the price paid by the four largest federal pharmaceutical-drug purchasers.\n\nThe CMS may (but is not required to)\u00a0negotiate lower prices on behalf of Medicare and MA beneficiaries for other covered prescription drugs.\n\nThe Government Accountability Office must report to Congress on the CMS' negotiations.\n\nThe Center for Medicare and Medicaid Innovation must test\u00a0several specified\u00a0models for negotiating drug and biological prices."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate lower covered part D drug prices on behalf of Medicare beneficiaries.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Drug and Health Improvement Act of 2017", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Prescription Drug and Health Improvement Act of 2017", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Prescription Drug and Health Improvement Act of 2017", 
      "type": "display"
    }
  ], 
  "updated_at": "2019-04-18T16:32:50Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/115/s/BILLSTATUS-115s348.xml"
}